摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2H5)苯氧基]乙酸 | 154492-74-7

中文名称
[(2H5)苯氧基]乙酸
中文别名
——
英文名称
phenoxyacetic-d5 acid
英文别名
Phenoxy-d5-acetic Acid;2-(2,3,4,5,6-pentadeuteriophenoxy)acetic acid
[(2H5)苯氧基]乙酸化学式
CAS
154492-74-7
化学式
C8H8O3
mdl
——
分子量
157.11
InChiKey
LCPDWSOZIOUXRV-RALIUCGRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    96 - 100°C
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:5c4a2aeafd47647c88381316f6c5d185
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [(2H5)苯氧基]乙酸氯化亚砜 作用下, 生成 phenoxyacetyl-d5 chloride
    参考文献:
    名称:
    Method of using deuterated calcium channel blockers
    摘要:
    一种增强药物效率和延长作用时间的方法(例如二氢吡啶和抗生素),特别是对于硝苯地平和青霉素,其中一个或多个氢原子被氘代替,氘代药物的性能比未经修改的药物在使用更低浓度时有意想不到的改善。还公开了一种确定新药物的身份和生物等效性的方法,其中通过同位素比质谱法确定新药物的分子和同位素结构,并与已知人用药物的分子和同位素结构进行比较。
    公开号:
    US06334997B1
  • 作为产物:
    描述:
    Phenoxy-d5-acetic Acid Ethyl Ester 在 氘氧化钠 作用下, 生成 [(2H5)苯氧基]乙酸
    参考文献:
    名称:
    Method of using deuterated calcium channel blockers
    摘要:
    一种增强药物效率和延长作用时间的方法(例如二氢吡啶和抗生素),特别是对于硝苯地平和青霉素,其中一个或多个氢原子被氘代替,氘代药物的性能比未经修改的药物在使用更低浓度时有意想不到的改善。还公开了一种确定新药物的身份和生物等效性的方法,其中通过同位素比质谱法确定新药物的分子和同位素结构,并与已知人用药物的分子和同位素结构进行比较。
    公开号:
    US06334997B1
点击查看最新优质反应信息

文献信息

  • Method of making and using isotope-substituted anti-bacterial agents
    申请人:——
    公开号:US20040253180A1
    公开(公告)日:2004-12-16
    A method of enhancing the efficiency and increasing the duration of action of drugs (e.g. dihydropyridines and anti-bacterials) and particularly of nifedipine and penicillins wherein one or more hydrogen atoms are deuterated and wherein the deuterated drug has unexpectedly improved properties when used in much lower concentrations than unmodified drug. A method for determining the identity and bioequivalency of a new drug is also disclosed wherein the molecular and isotope structure of a new drug is determined by isotope ratio mass spectrometry and compared with the molecular and isotope structure of a known human drug.
    一种增强药物效率和延长作用时间的方法(例如二氢吡啶和抗菌药物),特别是对于硝苯地平和青霉素,其中一个或多个氢原子被氘代替,而且氘代药物在使用时比未经改良的药物低得多的浓度下具有意外改善的性质。还公开了一种确定新药物身份和生物等效性的方法,其中通过同位素比质谱确定新药物的分子和同位素结构,并与已知的人类药物的分子和同位素结构进行比较。
  • Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of <i>Trypanosoma brucei</i>
    作者:Laura A. T. Cleghorn、Sébastien Albrecht、Laste Stojanovski、Frederick R. J. Simeons、Suzanne Norval、Robert Kime、Iain T. Collie、Manu De Rycker、Lorna Campbell、Irene Hallyburton、Julie A. Frearson、Paul G. Wyatt、Kevin D. Read、Ian H. Gilbert
    DOI:10.1021/acs.jmedchem.5b00596
    日期:2015.10.8
    There is an urgent need for new, brain penetrant small molecules that target the central nervous system second stage of human African trypanosomiasis (HAT). We report that a series of novel indoline-2carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture. We describe the optimization and characterization of this series. Potent antiproliferative activity was observed. The series demonstrated excellent pharmacokinetic properties, full cures in a stage 1 mouse model of HAT, and a partial cure in a stage 2 mouse model of HAT. Lack of tolerability prevented delivery of a fully curative regimen in the stage 2 mouse model and thus further progress of this series.
  • Skeletal rearrangements preceding CO loss from metastable phenoxymethylene ions derived from phenoxyacetic acid and anisole
    作者:Tineke A. Molenaar-Langeveld、Steen Ingemann、Nico M. M. Nibeering
    DOI:10.1002/oms.1210281031
    日期:1993.10
    AbstractThe loss of CH2˙ from the molecular ion of phenoxyacetic acid and the expulsion of an H˙ atom from ionized anisole lead to phenoxymethylen ions, which fragment predominantly by CO loss on the microsecond time‐scale. Carbon‐13 labelling reveals that ∼90% of the CO molecules expelled from the metastable ions derived from phenoxyacetic acid incorporate the carbon atom from the 1‐position of the phenyl group of the parent compound, whereas the residual CO molecules contain one of the other carbon atoms of the aromatic ring. The 2‐fluoro‐ and 2‐methylphenoxymethylene ions derived from the appropriate aryloxyacetic acids behave similarly, i.e. the carbon atom of the methylene group of the parent compound is not incorporated in the expelled CO molecules. In contrast, ∼45% of the CO molecules eliminated from the metastable phenoxymethylene ions formed from ionized anisole contain the carbon atom of the methyl group, while the remaining part contains the carbon atom from the 1‐position of the phenyl ring of the parent compound. This result is taken as evidence for the occurrence of a skeletal rearrangement of the anisole molecular ion leading to an interchange between the carbon atom of the methyl group and the carbon atom at the 1‐position of the ring. The elimination of CO from the metastable ions generated from either phenoxyacetic acid or anisole gives rise to a composite metastable peak. Conclusive evidence as to the formation of [C7H7O]+ isomers other than the phenoxymethylene ion is not obtained, indicating that the composite metastable peak is a result of two competing reactions both leading to CO loss. Possible mechanisms of these reactions are discussed together with the mechanism of the skeletal rearrangement of the molecular ion of anisole prior to H˙ loss.
  • US5846514A
    申请人:——
    公开号:US5846514A
    公开(公告)日:1998-12-08
  • US6334997B1
    申请人:——
    公开号:US6334997B1
    公开(公告)日:2002-01-01
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐